Scancell Holdings plc (AIM:SCLP)
London · Delayed Price · Currency is GBP · Price in GBX 9.60
+0.04 (0.42%)
Aug 14, 2026, 4:18 PM GMT
Scancell Holdings Market Cap
Scancell Holdings has a market cap or net worth of 116.37 million as of August 14, 2026. Its market cap has increased by 6.80% in one year.
Market Cap
116.37M
Enterprise Value
123.98M
Revenue
4.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.60
ChartMarket Cap Chart
Since June 29, 2009, Scancell Holdings's market cap has increased from 3.13M to 116.37M, an increase of 3,613.23%. That is a compound annual growth rate of 23.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 116.37M | 13.27% |
| Dec 31, 2025 | 102.74M | -6.96% |
| Dec 31, 2024 | 110.43M | 28.31% |
| Dec 29, 2023 | 86.06M | -57.34% |
| Dec 30, 2022 | 201.77M | 23.75% |
| Dec 31, 2021 | 163.04M | 42.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Avacta Group | 302.12M |
| PureTech Health | 292.59M |
| Faron Pharmaceuticals Oy | 91.98M |
| 4basebio | 85.46M |
| Bioventix | 78.37M |
| Ondine Biomedical | 71.44M |
| Poolbeg Pharma | 66.04M |
| hVIVO | 46.03M |